These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11221715)

  • 1. Pharmacogenomics.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT40-2. PubMed ID: 11221715
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomas: battling side effects with physiotypes.
    McDonald J
    Yale J Biol Med; 2007 Dec; 80(4):187-90. PubMed ID: 18449393
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics: the implementation phase.
    Sadee W
    AAPS PharmSci; 2002; 4(2):E5. PubMed ID: 12141268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging the knowledge gaps in vaccine design.
    Rappuoli R
    Nat Biotechnol; 2007 Dec; 25(12):1361-6. PubMed ID: 18066025
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech industry tries to recover from 2-year lull.
    Brower V
    J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
    [No Abstract]   [Full Text] [Related]  

  • 7. 454 life sciences: illuminating the future of genome sequencing and personalized medicine.
    Patrick K
    Yale J Biol Med; 2007 Dec; 80(4):191-4. PubMed ID: 18449390
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug discovery and development in the age of molecular medicine.
    Vallance P; Levick M
    Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genset-Abbott deal heralds pharmacogenomics era.
    Marshall A
    Nat Biotechnol; 1997 Sep; 15(9):829-30. PubMed ID: 9306389
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics and diagnostics.
    Persidis A
    Nat Biotechnol; 1998 Aug; 16(8):791-2. PubMed ID: 9702782
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech drugs come of age; policymakers take notice.
    Iglehart JK
    Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
    [No Abstract]   [Full Text] [Related]  

  • 12. Arnold Demain.
    Demain A
    Nat Biotechnol; 2011 Mar; 29(3):193. PubMed ID: 21390012
    [No Abstract]   [Full Text] [Related]  

  • 13. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 15. Charting the biologic frontier. Interview by Val J. Halamandaris.
    Venter C
    Caring; 2003 Apr; 22(4):32-40. PubMed ID: 12722564
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 17. China's biotech is starting to bloom.
    Stipp D
    Fortune; 2002 Sep; 146(4):126-30, 132, 134. PubMed ID: 12195673
    [No Abstract]   [Full Text] [Related]  

  • 18. R&D deals boom in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
    [No Abstract]   [Full Text] [Related]  

  • 19. Microarray technology: an array of opportunities.
    Gershon D
    Nature; 2002 Apr; 416(6883):885-91. PubMed ID: 11976691
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.